ARS Pharmaceuticals Inc (SPRY)
13.38
-0.17
(-1.25%)
USD |
NASDAQ |
Nov 21, 16:00
13.95
+0.57
(+4.26%)
After-Hours: 05:18
ARS Pharmaceuticals Gross Profit Margin (Quarterly): 94.58% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 94.58% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
94.58%
Minimum
Sep 2024
94.58%
Maximum
Sep 2024
94.58%
Average
94.58%
Median
Sep 2024
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -22.16% |
| Return on Assets | -21.37% |
| Return on Invested Capital | -22.16% |
| Profit Margin (Quarterly) | -925.0% |
| Operating Margin (Quarterly) | -1.05K% |
| Return on Net Operating Assets | -884.8% |